GlassScriptPhysician profile
Andrew F Colhoun
NPI 1396006961
$19,018.98
in general payments reported to CMS, 2019-2025
56 companies · $3,130 in 2025
The $3,130 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,201 · 2020: $1,411 · 2021: $2,842 · 2022: $3,308 · 2023: $3,073 · 2024: $3,053 · 2025: $3,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,148 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $78.61 · Education: $29.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,148.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $78.61 |
| Education | $29.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,670.68 | 2019-2025 | Titan |
| Dendreon Pharmaceuticals LLC | $2,218.38 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $1,160.67 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $988.59 | 2019-2025 | Erleada, Akeega |
| Abbvie INC. | $978.89 | 2019-2025 | Botox, Lupron Depot |
| Urogen Pharma, INC. | $945.02 | 2020-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $909.17 | 2019-2025 | |
| Blue Earth Diagnostics | $857.26 | 2019-2025 | Posluma |
| Antares Pharma, INC. | $794.15 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Endo Pharmaceuticals INC. | $694.50 | 2019-2024 | Xiaflex, Aveed, Edex |
| Astellas Pharma US INC | $559.24 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Novartis Pharmaceuticals Corporation | $545.25 | 2022-2025 | |
| Pfizer INC. | $529.57 | 2019-2024 | |
| Progenics Pharmaceuticals, INC. | $439.08 | 2022-2025 | Pylarify |
| Merck Sharp & Dohme LLC | $383.19 | 2020-2025 | Keytruda, Welireg, Lynparza |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $347.40 | 2019-2025 | Adstiladrin |
| Endo USA, INC. | $345.57 | 2024-2025 | Xiaflex, Aveed |
| Urovant Sciences INC | $276.27 | 2021-2022 | |
| Travere Therapeutics, INC. | $247.86 | 2019-2022 | |
| Amgen INC. | $231.09 | 2020-2023 | Prolia |
| Karl Storz Endoscopy-America | $213.84 | 2019-2022 | |
| Calyxo, INC. | $209.61 | 2025 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $206.34 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Astrazeneca Pharmaceuticals LP | $174.65 | 2020-2021 | |
| Teleflex LLC | $147.03 | 2021-2025 | Urolift, Barrigel |
| Sun Pharmaceutical Industries INC. | $146.64 | 2019-2024 | Yonsa |
| Ambu INC. | $144.94 | 2022-2024 | |
| Tolmar Pharmaceuticals, INC. | $124.80 | 2019-2022 | |
| Neotract INC. | $122.81 | 2020 | |
| Allergan, INC. | $109.45 | 2019-2020 | |
| Tempus Ai, INC | $106.87 | 2024-2025 | Xt Cdx |
| Medtronic USA, INC. | $106.18 | 2019 | |
| Rochester Medical Corporation | $97.06 | 2019-2022 | |
| Myovant Sciences INC. | $94.57 | 2021-2022 | |
| Cycle Pharmaceuticals INC | $84.50 | 2024-2025 | Venxxiva, Tiopronin |
| Genzyme Corporation | $81.96 | 2019-2023 | |
| Accord Healthcare, INC. | $80.22 | 2022-2024 | |
| Procept Biorobotics Corporation | $66.35 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Olympus America INC. | $60.57 | 2025 | Itind System |
| Boston Scientific Corporation | $56.57 | 2019-2025 | Rezum Generator |
| Photocure INC | $49.78 | 2019-2021 | |
| Cardinal Health 414 LLC | $49.05 | 2024-2025 | |
| Inspire Medical Systems, INC. | $47.02 | 2025 | Inspire |
| Halozyme INC | $44.61 | 2023 | |
| Foundation Medicine, INC. | $44.29 | 2020-2022 | |
| Azurity Pharmaceuticals, INC. | $43.40 | 2025 | Azmiro |
| Axonics, INC. | $28.75 | 2022-2023 | Axonics |
| Janssen Scientific Affairs, LLC | $27.71 | 2019 | |
| Tolmar, INC. | $24.05 | 2023 | |
| Mission Pharmacal Company | $21.13 | 2019 | |
| Telix Pharmaceuticals | $17.70 | 2022 | |
| Myriad Genetic Laboratories, INC. | $14.44 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $13.90 | 2023 | Bard Urinary Drainage Bag |
| Kowa Pharmaceuticals America, INC. | $13.06 | 2023 | Seglentis |
| Civco Medical Instruments | $12.05 | 2025 | |
| Metuchen Pharmaceuticals | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Colhoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.